Skip to main content
. Author manuscript; available in PMC: 2024 Mar 14.
Published in final edited form as: PRX Life. 2023 Dec 15;1(2):023009. doi: 10.1103/prxlife.1.023009

TABLE VI.

Cancer Drug Response models.

Model Name PMID Nodes Source Nodes Mean Regulators δs,p φa,f
Bortezomib Responses in U266 Human Myeloma Cells 26163548 67 1 1.8955 0.9147 0.2231
BT474 Breast Cell Line Long-term ErbB Network 24970389 24 5 3.0417 0.9439 0.3230
BT474 Breast Cell Line Short-term ErbB Network 24970389 16 5 3.1875 0.7614 0.1873
HCC1954 Breast Cell Line Long-term ErbB Network 24970389 23 4 3.1304 0.9643 0.4022
HCC1954 Breast Cell Line Short-term ErbB Network 24970389 16 5 3.1875 0.7841 0.1934
SKBR3 Breast Cell Line Long-term ErbB Network 24970389 25 4 3.4000 0.9458 0.2841
SKBR3 Breast Cell Line Short-term ErbB Network 24970389 16 5 2.8750 0.7908 0.3197
Treatment of Castration-Resistant Prostate Cancer 28361666 42 14 1.5476 0.9964 0.0000